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The data supplied in this work are related to the research article
entitled “IL-17A neutralizing antibody regulates monosodium
urate crystal-induced gouty inﬂammation” [1]. This data article
presents the results of the gating strategy applied to identify Treg
population in peripheral blood of mice injected with MSU crystals
and MSU crystals þ interleukin-17 antibody (IL-17Ab). Lastly, this
article provides in-depth immunophenotyping data relating to all
speciﬁc and isotype control antibodies used in the phenotypical
characterization of circulating Treg (deﬁned as
CD4þCD25þFoxp3þ), Th17 (deﬁned as CD4þIL-17þ) cells and joint-
inﬁltrated (in situ) inﬂammatory monocytes (deﬁned as
B220GR1highF480highCD115þ).
© 2019 The Author(s). Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).j.phrs.2019.104351.
aione).
vier Inc. This is an open access article under the CC BY-NC-ND license (http://
Speciﬁcations Table
Subject Pharmacology
Speciﬁc subject area Immunopharmacology
Type of data Imaging ﬂow cytometry data, image analysis of dot plots
How data were acquired BriCyte E6 ﬂow cytometer with MRFlow and FlowJo software operation
Data format Analysed data, raw data
Parameters for data collection N ¼ 6 samples from digested ankle joints and peripheral blood in each experimental
condition
Description of data collection The data obtained were expressed as the mean ± SD of ﬂow cytometry raw data
Data source location ImmunoPharmaLab, Department of Pharmacy, School of Medicine and Surgery,
University of Naples Federico II, Naples, Italy
Data accessibility Data are presented in this article
Related research article F. Raucci, A.J. Iqbal, A. Saviano, P. Minosi, M. Piccolo, C. Irace, F. Caso, R. Scarpa, S. Pieretti,
N. Mascolo, F. Maione. IL-17A neutralizing antibody regulates monosodium urate
crystal-induced gouty inﬂammation. Pharmacol Res. 2019 Jul 14:104351. https://doi.
org/10.1016/j.phrs.2019.104351.
Value of the data
 Increased conﬁdence in data from circulating Treg/Th17 cells and in situ inﬁltrated inﬂammatory monocytes of MSU
crystals-injected mice.
 Increased opportunities for collaborations with distant institutions up to 48 h shipping samples.
 Multiple samples collected for one day can be analysed in a batch the following day, thus increasing the efﬁciency of
laboratory personnel analysing samples.
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Our data indicate a correlation between the administration of IL-17 neutralizing antibody (IL-17Ab)
and a reduction in circulating Th17 cells (deﬁned as CD4þIL-17þ) and in situ inﬁltrated inﬂammatory
monocytes (deﬁned as B220GR1highF480highCD115þ) in a mouse model of gouty inﬂammation.
However, administration of IL-17Ab did not interfere with circulating Treg levels (deﬁnes as
CD4þCD25þFoxp3þ) [1].
The methodology for the determination of these cell subsets is based on a standardized ﬂow
cytometry gating strategy and data analysis of related isotype control antibodies. The data presented
here contribute to the understanding of the real percentage of Th17 cells and inﬂammatory monocytes
presented in our recent published paper [1].
In particular, to identify the systemic Treg and Th17 balance, we stained isolated peripheral lym-
phocytes cells with an anti-CD4, an accessory protein for MHC class-II antigen/T-cell receptor inter-
action, an anti-CD8, a marker that identiﬁes cytotoxic/suppressor T-cells that interacts with MHC class
I. We also stained isolated peripheral lymphocytes with an anti-CD4/IL-17 and anti-CD4/CD25/Foxp3 to
identify Th17 and Treg population respectively.
For Treg, we ﬁrst established the gate for cells that were positive for CD4 and then gated for CD25
and Foxp3 (Fig. 1). Dot plots values indicate the percentage of positively stained cells in the different
experimental conditions and are presented as means ± SD of n ¼ 6 mice per group (Table 1).
These values were strengthened by low percentage of positive cells found in all the staining for the
related isotype control antibodies (Fig. 2). Data are presented as means ± SD of n ¼ 6 mice per group
(Table 2).
Finally, we also report the percentage of positive cells found in all the staining for the isotype control
antibodies related to B220GR1highF480highCD115þcells (Fig. 3). Data are presented as means ± SD of
n ¼ 6 mice per group (Table 3).
Fig. 1. Gating strategy applied to identify CD4/CD25/Foxp3 positive cells. Lymphocytes isolated fromwhole blood by Ficoll-Paque
Plus gradient method were washed, gated in their totality (A, gate R1) and singlets (B, gate R2) for the identiﬁcation of CD4 positive
cells (C, E and G). Finally, CD4þ cells (gate R3) were plotted for CD25 and Foxp3 (D, F and H). Dot plots values indicated the per-
centage of positively stained cells in the different experimental conditions. FACS pictures are representative of six samples with
similar results. Data are presented as means ± SD of n ¼ 6 mice per group.
F. Raucci et al. / Data in brief 25 (2019) 104381 32. Experimental design, materials, and methods
CD-1malemice (Charles River, Italy) weighing 25e30 gwere used in all the experiments. Micewere
housed in colony cages (sixmice per cage) under standard conditions of light, temperature, and relative
humidity for at least one week before the start of experimental procedures. Food and water were
available ad libitum. All experiments were performed according to Legislative Decree 26/14, which
implements the European Directive 2010/63/UE on laboratory animal protection in Italy, and were
approved by the local Ethics Committee. According to the protocol described by Akitsu and colleagues
[2] ankle joints of CD-1 mice were removed and digested with hyaluronidase (2.4mg ml1) and
collagenase (1mg ml1) in RPMI 1640 plus 10% FBS for 1h at 37 C after the induction of experimentalTable 1
Raw data related to CD4/CD25/Foxp3 positive cells.
CD25/Foxp3 Ctrl MSU MSU þ IL-17Ab
0.20 1.35 0.40
0.21 1.27 0.26
0.28 1.20 0.33
0.30 1.19 0.61
0.27 1.41 0.54
0.36 0.84 0.86
Mean ± SD 0.27 ± 0.06 1.21 ± 0.20 0.50 ± 0.22
Fig. 2. Strategy applied to identify potential positive cells with isotype control antibodies. Lymphocytes isolated from whole
blood by Ficoll-Paque Plus gradient method were washed, stained with CD4 (A), CD8 (B), CD4/IL-17 (C) or CD25/Foxp3 (D) isotype
control antibodies and analysed by FACS. The numbers in the histograms and dot plots indicated the percentage of positively stained
cells in the different experimental conditions. FACS pictures are representative of six samples with similar results. Data are presented
as means ± SD of n ¼ 6 mice per group.
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Table 2
Raw data related to CD4, CD8, CD4/IL-17 and CD25/Foxp3 positive cells with isotype control antibodies.
CD4 Ctrl MSU MSU þ IL-17Ab
0.38 0.94 0.31
0.42 0.86 0.49
0.81 1.12 0.29
0.36 0.74 0.64
0.54 0.46 0.26
0.61 0.68 0.71
Mean ± SD 0.52 ± 0.17 0.80 ± 0.23 0.45 ± 0.19
CD8 Ctrl MSU MSU þ IL-17Ab
1.62 1.12 1.34
1.13 0.96 1.29
1.26 0.84 1.57
0.95 0.75 1.20
1.38 1.23 1.12
1.46 0.62 0.98
Mean ± SD 1.30 ± 0.24 0.92 ± 0.23 1.25 ± 0.20
CD4/IL-17 Ctrl MSU MSU þ IL-17Ab
0.10 0.52 0.26
0.04 0.14 0.06
0.09 0.29 0.14
0.25 0.41 0.09
0.11 0.69 0.21
0.01 0.23 0.02
Mean ± SD 0.10 ± 0.08 0.38 ± 0.20 0.13 ± 0.09
CD25/Foxp3 Ctrl MSU MSU þ IL-17Ab
0.02 0.33 0.01
0.12 0.23 0.04
0.19 0.17 0.09
0.08 0.09 0.03
0.11 0.46 0.08
0.08 0.22 0.11
Mean ± SD 0.10 ± 0.06 0.25 ± 0.13 0.06 ± 0.04
F. Raucci et al. / Data in brief 25 (2019) 104381 5gouty inﬂammation. The model was induced by the intra-articular (i.a.) administration of MSU crystals
(200 mg/20 ml) into the right knee joint of mice under isoﬂurane anaesthesia. Control animals received
an i.a. injection of PBS (20 ml) or IL-17Ab isotype control (20 ml). Animals from IL-17Ab-treated groups
received the selected dose of 10 mg (i.a.) of neutralizing antibody 30 minutes after MSU crystals
administration. The cells obtained at 18h post model induction (peak of inﬂammation) were ﬁltered
through a cell strainer with a 70-mm nylon mesh (Becton Dickinson, Franklin Lakes, NJ, USA) and
washed with RPMI 1640 plus 10% FBS. Thereafter, collected cells were washed in PBS before ﬂow
cytometry procedure and analysis as previously described [3,4]. For the characterization of joint-
inﬁltrating cells we performed additional stainings with GR1 (1:300; clone RB6-8C5), F480 (1:300;
clone BM8), B220 (1:200; clone RA3-6B2) and CD115 (1:200; clone AFS98) antibody for 60 minutes at
4 C. Inﬂammatory monocytes were deﬁned as B220GR1highF480highCD115þcells. Lymphocytes iso-
lated from whole blood by Ficoll-Paque Plus gradient method were washed in FACS buffer (PBS con-
taining 1% BSA and 0.02% NaN2) and directly stainedwith the following conjugated antibodies (all from
BioLegend, London, UK): CD4 (1:200; clone GK1.5), CD8 (1:200; clone 5H10-1), CD25 (1:200; clone
3C7) for 60minutes at 4 C. After washing, cells were ﬁxated, permeabilized, and stained intracellularly
with IL-17 (1:200; clone TC11-18H10.1) and Foxp3 antibodies (1:200: clone MF-14). Th17 and Treg
populationwere deﬁned as CD4þIL-17þ and CD4þCD25þFoxp3þ cells respectively. At least 1104 cells
were analysed per sample, and determination of positive and negative populations was performed
based on the staining obtained with related IgG isotypes. Flow cytometry was performed on BriCyte E6
ﬂow cytometer (Mindray Bio-Medical Electronics, Nanshan, China) using MRFlow and FlowJo software
operation. The data and statistical analysis presented here comply with the international recom-
mendations on experimental design and analysis in pharmacology and data sharing and presentation
in preclinical pharmacology [5e7]. The results obtained were expressed as the mean ± SD. Statistical
Fig. 3. Strategy applied to identify potential positive cells with isotype control antibodies. Cells obtained from ankle joints
digestion protocol were washed and successively stained with GR1 (AeC), F480 (DeF), B220 (GeI) and CD115 (JeL) isotype control
antibodies and analysed by FACS. The numbers in the histograms indicated the percentage of positively stained cells in the different
experimental conditions. FACS pictures are representative of six samples with similar results. Data are presented as means ± SD of
n ¼ 6 mice per group.
Table 3
Raw data related to GR1, F480, B220 and CD115 positive cells with isotype control antibodies.
GR1 Ctrl MSU MSU þ IL-17Ab
0.24 0.62 0.62
0.41 0.28 0.39
0.68 0.54 0.42
0.24 0.36 0.91
0.37 0.51 0.54
0.52 0.69 0.72
Mean ± SD 0.41 ± 0.17 0.50 ± 0.15 0.60 ± 0.19
F480 Ctrl MSU MSU þ IL-17Ab
0.21 0.14 0.21
0.08 0.08 0.16
0.34 0.21 0.34
0.51 0.11 0.09
0.10 0.05 0.11
0.14 0.25 0.05
Mean ± SD 0.23 ± 0.17 0.14 ± 0.08 0.16 ± 0.10
B220 Ctrl MSU MSU þ IL-17Ab
1.27 0.64 1.12
1.33 0.81 0.94
1.06 0.52 1.26
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1.11 1.21 0.84
0.97 0.47 0.44
1.46 1.09 1.10
Mean ± SD 1.20 ± 0.18 0.79 ± 0.30 0.95 ± 0.29
CD115 Ctrl MSU MSU þ IL-17Ab
0.01 0.01 0.02
0.12 0.09 0.09
0.09 0.11 0.11
0.15 0.04 0.01
0.21 0.06 0.07
0.02 0.11 0.12
Mean ± SD 0.10 ± 0.08 0.07 ± 0.04 0.07 ± 0.05
F. Raucci et al. / Data in brief 25 (2019) 104381 7analysis were performed by using one-way ANOVA followed by Bonferroni or Dunnett's post-test,
when comparing more than two groups. GraphPad Prism 7.0 software (San Diego, CA, USA) was used
for analysis. Data were considered statistically signiﬁcant when a value of P  0.05 was achieved.
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